Recommendation ID
NG14/05
Question

Surveillance strategies: How frequently should surveillance imaging be conducted, and which imaging modality should be used for people with stage IIB to IIIC melanoma?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made this recommendation for research, see the rationale and section on follow-up after treatment for melanoma.

Full details of the evidence and the committee's discussion are in evidence review G: follow-up of people with melanoma.


Source guidance details

Comes from guidance
Melanoma: assessment and management
Number
NG14
Date issued
July 2015

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/07/2022